|
Sections |
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 8 |
| 1.1 List of Tables | 7 | 2 |
| 1.2 List of Figures | 9 | 1 |
| 2 Introduction | 10 | 1 |
| 2.1 What Is This Report About? | 10 | 1 |
| 3 Definitions of Markets Covered in This Report | 11 | 2 |
| 3.1 Nephrology and Urology Devices | 11 | 1 |
| 3.2 Incontinence Devices | 11 | 1 |
| 3.2.1 Protective garments for incontinence | 11 | 1 |
| 3.2.2 Urine Bags | 11 | 1 |
| 3.2.3 Urinary Catheters | 11 | 1 |
| 3.3 Renal Dialysis Equipment | 11 | 1 |
| 3.3.1 Hemodialysis Machines | 11 | 1 |
| 3.3.2 Peritoneal Dialysis Solutions | 11 | 1 |
| 3.3.3 Continuous Renal Replacement Therapy Machines | 12 | 1 |
| 3.3.4 Dialysis Accessories | 12 | 1 |
| 3.3.4.1 AV Fistula Needles | 12 | 1 |
| 3.3.4.2 Blood Tubing Sets | 12 | 1 |
| 3.3.4.3 Dialysis Catheters | 12 | 1 |
| 3.3.4.4 Dialyzers | 12 | 1 |
| 3.4 Lithotripters | 12 | 1 |
| 4 Healthcare Sector Review | 13 | 8 |
| 4.1 Healthcare Expenditure | 13 | 4 |
| 4.2 Healthcare Infrastructure | 17 | 3 |
| 4.3 Healthcare Policy | 20 | 1 |
| 4.3.1 Health Insurance Act | 20 | 1 |
| 4.3.2 Healthcare Allowance Act | 20 | 1 |
| 4.3.3 The Exceptional Medical Expenses Act | 20 | 1 |
| 5 Regulation System | 21 | 13 |
| 5.1 Medical Equipment Approval Process | 21 | 1 |
| 5.1.1 Classification of Medical Devices | 22 | 8 |
| 5.1.2 Conformity Assessment Process | 30 | 1 |
| 5.1.2.1 Class I devices | 30 | 1 |
| 5.1.2.2 Class IIa devices | 31 | 1 |
| 5.1.2.3 Class IIb devices | 32 | 1 |
| 5.1.2.4 Class III devices | 33 | 1 |
| 5.2 Post Market Surveillance (PMS) | 33 | 1 |
| 6 Pricing and Reimbursement | 34 | 1 |
| 6.1 Pricing and Reimbursement in Netherlands | 34 | 1 |
| 7 Distribution Structure | 35 | 1 |
| 7.1 Distribution Structure in Netherlands | 35 | 1 |
| 8 Nephrology and Urology Devices In Netherlands | 36 | 7 |
| 8.1 Nephrology and Urology Devices, Netherlands, Overall Revenue ($ mn), 2000-2015 | 36 | 4 |
| 8.2 Nephrology and Urology Devices, Netherlands, Category Volume (Units), 2000-2015 | 40 | 2 |
| 8.3 Nephrology and Urology Devices, Netherlands, Company Share (2007-2008) | 42 | 1 |
| 9 Incontinence Devices In Netherlands | 43 | 8 |
| 9.1 Incontinence Devices Overall Revenue (2000-2015) | 43 | 2 |
| 9.2 Incontinence Devices Overall Volume (2000-2015) | 45 | 2 |
| 9.3 Incontinence Devices Average Price (2000-2015) | 47 | 1 |
| 9.4 Incontinence Devices Distribution Share (2007-2008) | 48 | 1 |
| 9.5 Incontinence Devices, Netherlands, Company Share (2007-2008) | 49 | 2 |
| 10 Lithotripters In Netherlands | 51 | 7 |
| 10.1 Lithotripters Overall Revenue (2000-2015) | 51 | 2 |
| 10.2 Lithotripters Overall Volume (2000-2015) | 53 | 2 |
| 10.3 Lithotripters Average Price (2000-2015) | 55 | 1 |
| 10.4 Lithotripters Distribution Share (2007-2008) | 56 | 1 |
| 10.5 Lithotripters, Netherlands, Company Share (2007-2008) | 57 | 1 |
| 11 Renal Dialysis Equipment In Netherlands | 58 | 12 |
| 11.1 Renal Dialysis Equipment Overall Revenue (2000-2015) | 58 | 4 |
| 11.1.1 Dialysis Accessories Overall Revenue (2000-2015) | 62 | 2 |
| 11.2 Renal Dialysis Equipment Overall Volume (2000-2015) | 64 | 1 |
| 11.2.1 Dialysis Accessories Overall Volume (2000-2015) | 65 | 2 |
| 11.3 Renal Dialysis Equipment Average Price (2000-2015) | 67 | 1 |
| 11.4 Renal Dialysis Equipment Distribution Share (2007-2008) | 68 | 1 |
| 11.5 Renal Dialysis Equipment, Netherlands, Company Share (2007-2008) | 69 | 1 |
| 12 Overview of Key Companies in Netherlands Nephrology and Urology Devices Market | 70 | 18 |
| 12.1 Svenska Celullosa Aktiebolaget SCA | 70 | 1 |
| 12.1.1 Company Overview | 70 | 1 |
| 12.2 Fresenius Medical Care AG & Co. KGaA | 70 | 1 |
| 12.2.1 Company Overview | 70 | 1 |
| 12.3 Gambro AB | 71 | 1 |
| 12.3.1 Company Overview | 71 | 1 |
| 12.3.2 Gambro AB Pipeline Products | 71 | 1 |
| 12.3.2.1 Gambro AB Pipeline Products By Equipment Type | 71 | 1 |
| 12.3.2.2 Gambro AB Pipeline Products By Development Stage | 72 | 1 |
| 12.3.2.3 Gambro AB Pipeline Products By Therapy Area | 72 | 1 |
| 12.3.2.4 Gambro AB Pipeline Products By Clinical Trials | 73 | 1 |
| 12.4 Kimberly-Clark Corporation | 74 | 1 |
| 12.4.1 Company Overview | 74 | 1 |
| 12.5 HARTMANN GROUP | 74 | 1 |
| 12.5.1 Company Overview | 74 | 1 |
| 12.6 Coloplast A/S | 75 | 1 |
| 12.6.1 Company Overview | 75 | 1 |
| 12.7 Baxter International Inc. | 76 | 1 |
| 12.7.1 Company Overview | 76 | 1 |
| 12.7.2 Baxter International Inc. Pipeline Products | 76 | 1 |
| 12.7.2.1 Baxter International Inc. Pipeline Products By Equipment Type | 76 | 1 |
| 12.7.2.2 Baxter International Inc. Pipeline Products By Development Stage | 76 | 1 |
| 12.7.2.3 Baxter International Inc. Pipeline Products By Therapy Area | 77 | 1 |
| 12.7.2.4 Baxter International Inc. Pipeline Products By Clinical Trials | 77 | 1 |
| 12.7.2.5 Baxter International Inc. Pipeline Products By News Summary | 77 | 1 |
| 12.8 Teleflex Incorporated | 78 | 1 |
| 12.8.1 Company Overview | 78 | 1 |
| 12.9 STORZ MEDICAL AG | 78 | 1 |
| 12.9.1 Company Overview | 78 | 1 |
| 12.10 Siemens Healthcare | 79 | 1 |
| 12.10.1 Company Overview | 79 | 1 |
| 12.10.2 Siemens Medical Solutions Pipeline Products | 79 | 1 |
| 12.10.2.1 Siemens Medical Solutions Pipeline Products By Equipment Type | 79 | 1 |
| 12.10.2.2 Siemens Medical Solutions Pipeline Products By Development Stage | 80 | 1 |
| 12.10.2.3 Siemens Medical Solutions Pipeline Products By Therapy Area | 80 | 1 |
| 12.10.2.4 Siemens Medical Solutions Pipeline Products By Clinical Trials | 81 | 1 |
| 12.10.2.5 Siemens Medical Solutions Pipeline Products By News Summary | 81 | 1 |
| 12.11 ONTEX International N.V. | 82 | 1 |
| 12.11.1 Company Overview | 82 | 1 |
| 12.12 Dornier MedTech GmbH | 82 | 1 |
| 12.12.1 Company Overview | 82 | 1 |
| 12.13 Covidien Ltd. | 83 | 1 |
| 12.13.1 Company Overview | 83 | 1 |
| 12.14 C.R. Bard, Inc. | 84 | 1 |
| 12.14.1 Company Overview | 84 | 1 |
| 12.14.2 C.R. Bard, Inc. Pipeline Products | 84 | 1 |
| 12.14.2.1 C.R. Bard, Inc. Pipeline Products By Equipment Type | 84 | 1 |
| 12.14.2.2 C.R. Bard, Inc. Pipeline Products By Development Stage | 84 | 1 |
| 12.14.2.3 C.R. Bard, Inc. Pipeline Products By Therapy Area | 85 | 1 |
| 12.14.2.4 C.R. Bard, Inc. Pipeline Products By Clinical Trials | 85 | 1 |
| 12.15 B. Braun Melsungen AG | 86 | 1 |
| 12.15.1 Company Overview | 86 | 1 |
| 12.16 AstraZeneca PLC | 86 | 1 |
| 12.16.1 Company Overview | 86 | 1 |
| 12.17 Medical Enterprises Europe B.V. | 87 | 1 |
| 12.17.1 Company Overview | 87 | 1 |
| 12.17.2 Medical Enterprises Europe B.V. Pipeline Products | 87 | 1 |
| 12.17.2.1 Medical Enterprises Europe B.V. Pipeline Products By Equipment Type | 87 | 1 |
| 12.17.2.2 Medical Enterprises Europe B.V. Pipeline Products By Development Stage | 87 | 1 |
| 12.17.2.3 Medical Enterprises Europe B.V. Pipeline Products By Therapy Area | 87 | 1 |
| 12.17.2.4 Medical Enterprises Europe B.V. Pipeline Products By Clinical Trials | 87 | 1 |
| 13 Appendix | 88 | 5 |
| 13.1 Global Markets Direct Research Methodology | 88 | 1 |
| 13.2 Secondary Research | 89 | 1 |
| 13.3 Primary Research | 89 | 1 |
| 13.4 Models | 90 | 1 |
| 13.5 Forecasts | 90 | 1 |
| 13.6 Expert Panel Validation | 90 | 1 |
| 13.7 Currency Conversion | 91 | 1 |
| 13.8 Contact Us | 92 | 1 |
| 13.9 Disclaimer | 92 | 1 |